LFCR vs TSM
Lifecore Biomedical Inc. (LFCR) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
TSM (TSM) common stock.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
TSM does not have a complete income-statement cache yet.
LFCR currently screens at market cap $207.1M. TSM currently screens at market cap $0.
Not investment advice. Open the LFCR and TSM stock pages for the full models.
Not investment advice.